Log In
BCIQ
Print this Print this
 

SD118 (formerly NSL-043)

  Manage Alerts
Collapse Summary General Information
Company OncoSil Medical Ltd.
DescriptionReverses static allodynia and inhibits spontaneous ectopic discharge
Molecular Target Not available
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat neuropathic pain
Regulatory Designation
PartnerBeijing Tide Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
Get a free BioCentury trial today